Tekla Capital Management LLC
13F Reported Value
ⓘ$2.3B
Holdings
128
Latest Filing
2023-06-30
Filing Quarter
Q2 2023
Portfolio Overview
Tekla Capital Management LLC disclosed 128 positions worth $2.3B in its Form 13F-HR for Q2 2023, led by $AMGN (AMGEN INC) at 6.1% of the equity portfolio, followed by $JNJ and $GILD. During the quarter the fund opened 6 new positions and exited 11 — including a new stake in $PODD and a full exit from $TVTX. The portfolio is most concentrated in Healthcare (82.9% of disclosed assets). All figures are sourced directly from Tekla Capital Management LLC’s Form 13F-HR filing with the SEC under CIK 1300336.
AI Fund Analysis
StableSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q2 2023
Click any card to unlockTop Holdings
- 79.5#53
Quality
$136.9M616,539 sh - 72.8#214
Quality
$119.5M721,779 sh - 77.8#75
Quality
$118.2M1,533,884 sh - 75.1
Quality
$116.0M161,418 sh - 49.8
Quality
$111.9M318,043 sh - 66.8
Quality
$99.5M206,961 sh - 70.9
Quality
$84.0M728,154 sh - 59.3
Quality
$73.5M545,629 sh - 65.6
Quality
$70.6M247,943 sh - —
Quality
$69.9M976,676 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 AMGEN INC$AMGN | 79.5#53 | $136.9M | 616,539 |
 JOHNSON & JOHNSON$JNJ | 72.8#214 | $119.5M | 721,779 |
 GILEAD SCIENCES, INC.$GILD | 77.8#75 | $118.2M | 1,533,884 |
 REGENERON PHARMACEUTICALS, INC.$REGN | 75.1 | $116.0M | 161,418 |
 Vertex, Inc.$VERX | 49.8 | $111.9M | 318,043 |
 UNITEDHEALTH GROUP INC$UNH | 66.8 | $99.5M | 206,961 |
 Merck & Co., Inc.$MRK | 70.9 | $84.0M | 728,154 |
 AbbVie Inc.$ABBV | 59.3 | $73.5M | 545,629 |
 BIOGEN INC.$BIIB | 65.6 | $70.6M | 247,943 |
 ASTRAZENECA PLC$AZN | — | $69.9M | 976,676 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Tekla Capital Management LLC's 128 positions.
Showing top 10 of 128 holdings.
Sector Allocation
Healthcare
$1.9B
Technology
$241.9M
Industrials
$55.9M
Real Estate
$42.0M
Consumer Staples
$26.5M
Energy
$19.9M
Materials
$193,550
Full Holdings — Tekla Capital Management LLC (Q2 2023)
All 128 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $AMGN | AMGEN INC | $136.9M | 6.1% | +11% | 79.5 |
| 2 | $JNJ | JOHNSON & JOHNSON | $119.5M | 5.3% | +0% | 72.8 |
| 3 | $GILD | GILEAD SCIENCES, INC. | $118.2M | 5.2% | -2% | 77.8 |
| 4 | $REGN | REGENERON PHARMACEUTICALS, INC. | $116.0M | 5.1% | +13% | 75.1 |
| 5 | $VERX | Vertex, Inc. | $111.9M | 5.0% | -4% | 49.8 |
| 6 | $UNH | UNITEDHEALTH GROUP INC | $99.5M | 4.4% | -12% | 66.8 |
| 7 | $MRK | Merck & Co., Inc. | $84.0M | 3.7% | +32% | 70.9 |
| 8 | $ABBV | AbbVie Inc. | $73.5M | 3.3% | +7% | 59.3 |
| 9 | $BIIB | BIOGEN INC. | $70.6M | 3.1% | +3% | 65.6 |
| 10 | $AZN | ASTRAZENECA PLC | $69.9M | 3.1% | -2% | — |
| 11 |  $ILMN | ILLUMINA, INC. | $63.2M | 2.8% | -3% | 62.5 |
| 12 |  $ABT | ABBOTT LABORATORIES | $60.2M | 2.7% | -11% | 67 |
| 13 |  $PFE | PFIZER INC | $59.6M | 2.6% | -8% | 69 |
| 14 |  $TMO | THERMO FISHER SCIENTIFIC INC. | $51.6M | 2.3% | +6% | 63.7 |
| 15 |  $ELV | Elevance Health, Inc. | $50.7M | 2.3% | +0% | 59.4 |
| 16 |  $MRNA | Moderna, Inc. | $41.8M | 1.9% | +7% | 15.9 |
| 17 |  $BSX | BOSTON SCIENTIFIC CORP | $35.6M | 1.6% | +16% | 79.9 |
| 18 |  $DAN | DANA Inc | $34.3M | 1.5% | +35% | 60.9 |
| 19 |  $MDT | Medtronic plc | $30.3M | 1.4% | -0% | — |
| 20 |  $DXCM | DEXCOM INC | $29.4M | 1.3% | +0% | 77.9 |
| 21 |  $ISRG | INTUITIVE SURGICAL INC | $28.7M | 1.3% | -25% | 81.4 |
| 22 |  $ALNY | ALNYLAM PHARMACEUTICALS, INC. | $27.2M | 1.2% | +0% | 60.9 |
| 23 |  $MCK | MCKESSON CORP | $26.5M | 1.2% | -7% | 63.7 |
| 24 |  $ARGX | ARGENX SE | $25.5M | 1.1% | -26% | — |
| 25 |  $HCA | HCA Healthcare, Inc. | $25.0M | 1.1% | -7% | 70.5 |
| 26 |  $SYK | STRYKER CORP | $24.8M | 1.1% | +13% | 69.8 |
| 27 |  $IQV | IQVIA HOLDINGS INC. | $24.5M | 1.1% | +73% | 59.7 |
| 28 |  $ZTS | Zoetis Inc. | $23.6M | 1.1% | +0% | 72.6 |
| 29 |  $CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $23.4M | 1.0% | -6% | 47.1 |
| 30 |  $SE | Sea Ltd | $21.6M | 1.0% | -50% | — |
| 31 |  $SRPT | Sarepta Therapeutics, Inc. | $20.5M | 0.9% | -37% | 41.6 |
| 32 |  $NOV | NOV Inc. | $19.9M | 0.9% | +10% | 50.1 |
| 33 |  $OCS | Oculis Holding AG | $18.8M | 0.8% | +0% | — |
| 34 |  $MOH | MOLINA HEALTHCARE, INC. | $18.6M | 0.8% | +0% | 60.5 |
| 35 |  $JAZZ | Jazz Pharmaceuticals plc | $18.3M | 0.8% | +0% | — |
| 36 |  $BMRN | BIOMARIN PHARMACEUTICAL INC | $18.3M | 0.8% | -30% | 74.1 |
| 37 |  $EW | Edwards Lifesciences Corp | $17.9M | 0.8% | +11% | 67.6 |
| 38 |  $HUM | HUMANA INC | $16.5M | 0.7% | +0% | 82 |
| 39 |  $APLS | Apellis Pharmaceuticals, Inc. | $15.8M | 0.7% | +28% | 63.9 |
| 40 |  $BAX | BAXTER INTERNATIONAL INC | $14.8M | 0.7% | +382% | 45.7 |
| 41 |  $EXEL | EXELIXIS, INC. | $13.9M | 0.6% | +0% | 79.4 |
| 42 |  $NVS | NOVARTIS AG | $13.7M | 0.6% | +0% | — |
| 43 |  $PODD | INSULET CORP | $12.6M | 0.6% | NEW | 70.4 |
| 44 |  $GH | Guardant Health, Inc. | $12.4M | 0.6% | -27% | 36.1 |
| 45 |  $ASND | Ascendis Pharma A/S | $12.4M | 0.6% | +12% | 41.5 |
| 46 |  $THC | TENET HEALTHCARE CORP | $12.1M | 0.5% | NEW | 66.6 |
| 47 |  $BNTX | BioNTech SE | $11.2M | 0.5% | +0% | — |
| 48 |  $NBIX | NEUROCRINE BIOSCIENCES INC | $10.6M | 0.5% | +0% | 75.4 |
| 49 |  $ZBH | ZIMMER BIOMET HOLDINGS, INC. | $9.8M | 0.4% | +0% | 64.9 |
| 50 |  $RLYB | Rallybio Corp | $9.8M | 0.4% | +0% | — |
| 51 |  $PCVX | Vaxcyte, Inc. | $9.7M | 0.4% | +3785% | — |
| 52 |  $ALKS | Alkermes plc. | $9.7M | 0.4% | +0% | — |
| 53 |  $DNLI | Denali Therapeutics Inc. | $9.6M | 0.4% | +0% | — |
| 54 |  $AVTR | Avantor, Inc. | $9.4M | 0.4% | +0% | 38.4 |
| 55 |  $OHI | OMEGA HEALTHCARE INVESTORS INC | $9.4M | 0.4% | +0% | 63.2 |
| 56 |  $UTHR | UNITED THERAPEUTICS Corp | $9.2M | 0.4% | -32% | 80.1 |
| 57 |  $ACHC | Acadia Healthcare Company, Inc. | $8.0M | 0.4% | -46% | 49.3 |
| 58 |  $MDGL | MADRIGAL PHARMACEUTICALS, INC. | $8.0M | 0.3% | +176% | 25.4 |
| 59 |  $RMD | RESMED INC | $7.6M | 0.3% | -53% | 79.8 |
| 60 |  $INSP | Inspire Medical Systems, Inc. | $7.1M | 0.3% | NEW | 46 |
| 61 |  $CYTK | CYTOKINETICS INC | $7.1M | 0.3% | +0% | 28 |
| 62 |  $STE | STERIS plc | $7.0M | 0.3% | +0% | — |
| 63 |  $SNY | Sanofi | $6.7M | 0.3% | +0% | — |
| 64 |  $CVS | CVS HEALTH Corp | $6.5M | 0.3% | +0% | 51.3 |
| 65 |  $MEDP | Medpace Holdings, Inc. | $6.5M | 0.3% | +185% | 77.4 |
| 66 |  $IMVT | Immunovant, Inc. | $6.4M | 0.3% | +191% | — |
| 67 |  $NTLA | Intellia Therapeutics, Inc. | $6.3M | 0.3% | +0% | 24.5 |
| 68 |  $LTC | LTC PROPERTIES INC | $6.0M | 0.3% | +0% | 58.4 |
| 69 |  $SBRA | Sabra Health Care REIT, Inc. | $6.0M | 0.3% | +0% | 73.5 |
| 70 |  $SNN | SMITH & NEPHEW PLC | $5.9M | 0.3% | +0% | — |
| 71 |  $WST | WEST PHARMACEUTICAL SERVICES INC | $5.8M | 0.3% | +0% | 66.8 |
| 72 |  $LIVN | LivaNova PLC | $5.6M | 0.3% | +70% | — |
| 73 |  $A | AGILENT TECHNOLOGIES, INC. | $5.2M | 0.2% | +0% | 64.6 |
| 74 |  $QURE | uniQure N.V. | $4.1M | 0.2% | -45% | — |
| 75 |  $MPT | MEDICAL PROPERTIES TRUST INC | $3.8M | 0.2% | +0% | 42 |
| 76 |  $IONS | IONIS PHARMACEUTICALS INC | $3.6M | 0.2% | +0% | 37.1 |
| 77 |  $BCRX | BIOCRYST PHARMACEUTICALS INC | $3.6M | 0.2% | +0% | 37.2 |
| 78 |  $TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | $3.5M | 0.1% | +0% | — |
| 79 |  $WELL | WELLTOWER INC. | $3.4M | 0.1% | +0% | 75.7 |
| 80 |  $HR | Healthcare Realty Trust Inc | $3.3M | 0.1% | +0% | 44.9 |
| 81 |  $VTR | Ventas, Inc. | $3.2M | 0.1% | +0% | 70.3 |
| 82 |  $DOC | HEALTHPEAK PROPERTIES, INC. | $3.0M | 0.1% | +0% | 62 |
| 83 |  $ADPT | Adaptive Biotechnologies Corp | $2.8M | 0.1% | +0% | 35.2 |
| 84 |  $XENE | Xenon Pharmaceuticals Inc. | $2.6M | 0.1% | -19% | 12.9 |
| 85 |  $BBIO | BridgeBio Pharma, Inc. | $2.6M | 0.1% | +0% | 31.7 |
| 86 |  $CRBU | Caribou Biosciences, Inc. | $2.4M | 0.1% | +0% | 6.1 |
| 87 |  $ICLR | ICON PLC | $2.3M | 0.1% | +0% | — |
| 88 |  $AMLX | Amylyx Pharmaceuticals, Inc. | $2.2M | 0.1% | NEW | — |
| 89 |  $ASRT | Assertio Holdings, Inc. | $2.2M | 0.1% | +0% | 27.2 |
| 90 |  $MREO | Mereo BioPharma Group plc | $2.0M | 0.1% | +0% | — |
| 91 |  $ARDX | ARDELYX, INC. | $1.8M | 0.1% | +0% | 35.3 |
| 92 |  $PYXS | Pyxis Oncology, Inc. | $1.8M | 0.1% | +0% | — |
| 93 |  $PRGO | PERRIGO Co plc | $1.7M | 0.1% | +0% | — |
| 94 |  $TAK | TAKEDA PHARMACEUTICAL CO LTD | $1.7M | 0.1% | +0% | — |
| 95 |  $XRN | Chiron Real Estate Inc. | $1.6M | 0.1% | +0% | 61.8 |
| 96 |  $GSK | GSK plc | $1.5M | 0.1% | +0% | — |
| 97 |  $TCMD | TACTILE SYSTEMS TECHNOLOGY INC | $1.5M | 0.1% | +70% | 45.3 |
| 98 |  $ARQT | Arcutis Biotherapeutics, Inc. | $1.4M | 0.1% | +0% | 41.2 |
| 99 |  $XNCR | Xencor Inc | $1.4M | 0.1% | NEW | 13.1 |
| 100 |  $CRNX | Crinetics Pharmaceuticals, Inc. | $1.4M | 0.1% | +0% | 26.5 |
| 101 |  $CRSP | CRISPR Therapeutics AG | $1.3M | 0.1% | -59% | 4.5 |
| 102 |  $NTRA | Natera, Inc. | $1.2M | 0.1% | -50% | 46.4 |
| 103 |  $EWTX | Edgewise Therapeutics, Inc. | $1.2M | 0.1% | -23% | — |
| 104 |  $ZNTL | Zentalis Pharmaceuticals, Inc. | $1.1M | 0.1% | NEW | — |
| 105 |  $BCYC | BICYCLE THERAPEUTICS PLC | $1.1M | 0.1% | -50% | — |
| 106 |  $FULC | Fulcrum Therapeutics, Inc. | $847,730 | 0.0% | +339% | — |
| 107 |  $SRRK | Scholar Rock Holding Corp | $820,601 | 0.0% | +0% | — |
| 108 |  $DHC | DIVERSIFIED HEALTHCARE TRUST | $804,870 | 0.0% | +0% | 39.7 |
| 109 |  $RCUS | Arcus Biosciences, Inc. | $666,960 | 0.0% | +0% | 12 |
| 110 |  $BDTX | Black Diamond Therapeutics, Inc. | $666,550 | 0.0% | +0% | 57.5 |
| 111 |  $UHT | UNIVERSAL HEALTH REALTY INCOME TRUST | $535,656 | 0.0% | +0% | 54.6 |
| 112 |  $NHI | NATIONAL HEALTH INVESTORS INC | $526,192 | 0.0% | +0% | 68.3 |
| 113 |  $BEAM | Beam Therapeutics Inc. | $505,037 | 0.0% | +0% | 12.1 |
| 114 |  $TCRX | TScan Therapeutics, Inc. | $500,000 | 0.0% | +0% | 8.7 |
| 115 |  $ALXO | ALX ONCOLOGY HOLDINGS INC | $497,245 | 0.0% | +0% | — |
| 116 |  $CHCT | Community Healthcare Trust Inc | $491,998 | 0.0% | +0% | 51.5 |
| 117 |  $NVMI | NOVA LTD. | $474,034 | 0.0% | +0% | — |
| 118 |  $STRO | SUTRO BIOPHARMA, INC. | $457,346 | 0.0% | +0% | 30.1 |
| 119 |  $CYH | COMMUNITY HEALTH SYSTEMS INC | $388,674 | 0.0% | +0% | 53.4 |
| 120 |  $ALT | Altimmune, Inc. | $264,750 | 0.0% | +0% | 7.3 |
| 121 |  $CDXS | CODEXIS, INC. | $193,550 | 0.0% | +0% | 11.3 |
| 122 |  $DTIL | PRECISION BIOSCIENCES INC | $118,105 | 0.0% | +0% | 3.9 |
| 123 |  $ACET | Adicet Bio, Inc. | $97,999 | 0.0% | +0% | — |
| 124 |  $PRAX | Praxis Precision Medicines, Inc. | $86,250 | 0.0% | +0% | — |
| 125 |  $NKTX | Nkarta, Inc. | $63,484 | 0.0% | +0% | — |
| 126 |  $CRBP | Corbus Pharmaceuticals Holdings, Inc. | $40,321 | 0.0% | +0% | — |
| 127 |  $VYNE | VYNE Therapeutics Inc. | $30,531 | 0.0% | +0% | — |
| 128 |  $NXGL | NEXGEL, INC. | $10,650 | 0.0% | +0% | — |
New Positions (6)
Exited Positions (11)
$TVTX Travere Therapeutics, Inc.
$LNTH Lantheus Holdings, Inc.
$ADUS Addus HomeCare Corp
$KURA Kura Oncology, Inc.
$RARE Ultragenyx Pharmaceutical Inc.
$ARWR ARROWHEAD PHARMACEUTICALS, INC.
$SNDX Syndax Pharmaceuticals Inc
$ALGN ALIGN TECHNOLOGY INC
$OPCH Option Care Health, Inc.
$ZLAB Zai Lab Ltd
$BHVN Biohaven Ltd.Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Tekla Capital Management LLC including:
Track Tekla Capital Management LLC's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Tekla Capital Management LLC and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Tekla Capital Management LLC
13F Pro is an AI hedge fund tracker and stock research platform. For Tekla Capital Management LLC (SEC CIK: 1300336), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Tekla Capital Management LLC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.